Literature DB >> 8890263

MicroO-conotoxin MrVIA inhibits mammalian sodium channels, but not through site I.

H Terlau1, M Stocker, K J Shon, J M McIntosh, B M Olivera.   

Abstract

1. A 31-amino-acid peptide from the venom of the snail-hunting species Conus marmoreus, microO-conotoxin MrVIA, inhibits mammalian voltage-gated sodium channels through a novel mechanism distinct from saxitoxin, tetrodotoxin, or mu-conotoxin. 2. MicroO-Conotoxin MrVIA blocks rat brain type II sodium channels expressed in Xenopus oocytes (IC50 approximately 200 nM, Hill coefficient approximately 1.6 +/- 0.2, mean +/- SE). Channel activation/inactivation kinetics and current-voltage relationships were unperturbed. 3. MicroO-Conotoxin MrVIA does not cause phasic or use-dependent inhibition of sodium currents measured in Xenopus oocytes expressing rat brain type II sodium channels, but shifts the steady-state availability of these sodium channels to more hyperpolarized potentials. 4. MicroO-Conotoxin MrVIA inhibited rapidly inactivating sodium channel conductance in rat hippocampal cells in culture. The inhibition was rapidly reversible. 5. MicroO-Conotoxin MrVIA does not displace specific [3H]saxitoxin binding to either rat brain or Electrophorus electric organ sites, indicating inhibitory effects mediated through a binding site distinct from site I.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890263     DOI: 10.1152/jn.1996.76.3.1423

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  9 in total

1.  Navβ subunits modulate the inhibition of Nav1.8 by the analgesic gating modifier μO-conotoxin MrVIB.

Authors:  Michael J Wilson; Min-Min Zhang; Layla Azam; Baldomero M Olivera; Grzegorz Bulaj; Doju Yoshikami
Journal:  J Pharmacol Exp Ther       Date:  2011-05-17       Impact factor: 4.030

2.  Specificity, affinity and efficacy of iota-conotoxin RXIA, an agonist of voltage-gated sodium channels Na(V)1.2, 1.6 and 1.7.

Authors:  Brian Fiedler; Min-Min Zhang; Oga Buczek; Layla Azam; Grzegorz Bulaj; Raymond S Norton; Baldomero M Olivera; Doju Yoshikami
Journal:  Biochem Pharmacol       Date:  2008-04-06       Impact factor: 5.858

3.  Neurotoxins and their binding areas on voltage-gated sodium channels.

Authors:  Marijke Stevens; Steve Peigneur; Jan Tytgat
Journal:  Front Pharmacol       Date:  2011-11-09       Impact factor: 5.810

4.  Diversity of conotoxin gene superfamilies in the venomous snail, Conus victoriae.

Authors:  Samuel D Robinson; Helena Safavi-Hemami; Lachlan D McIntosh; Anthony W Purcell; Raymond S Norton; Anthony T Papenfuss
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

5.  The Venom Repertoire of Conus gloriamaris (Chemnitz, 1777), the Glory of the Sea.

Authors:  Samuel D Robinson; Qing Li; Aiping Lu; Pradip K Bandyopadhyay; Mark Yandell; Baldomero M Olivera; Helena Safavi-Hemami
Journal:  Mar Drugs       Date:  2017-05-20       Impact factor: 5.118

6.  Selecting Potential Neuronal Drug Leads from Conotoxins of Various Venomous Marine Cone Snails in Bali, Indonesia.

Authors:  Anak A R Sudewi; Ni M Susilawathi; Bayu K Mahardika; Agung N Mahendra; Made Pharmawati; Mark A Phuong; Gusti N Mahardika
Journal:  ACS Omega       Date:  2019-11-06

Review 7.  Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics?

Authors:  Oliver Knapp; Jeffrey R McArthur; David J Adams
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

8.  Phase coupling of a circadian neuropeptide with rest/activity rhythms detected using a membrane-tethered spider toxin.

Authors:  Ying Wu; Guan Cao; Beth Pavlicek; Xuan Luo; Michael N Nitabach
Journal:  PLoS Biol       Date:  2008-11-04       Impact factor: 8.029

9.  αM-Conotoxin MIIIJ Blocks Nicotinic Acetylcholine Receptors at Neuromuscular Junctions of Frog and Fish.

Authors:  Matthew J Rybin; Henrik O'Brien; Iris Bea L Ramiro; Layla Azam; J Michael McIntosh; Baldomero M Olivera; Helena Safavi-Hemami; Doju Yoshikami
Journal:  Toxins (Basel)       Date:  2020-03-21       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.